Pharma Meetings Compliance Venue Guide: How to Choose Hotels That Pass Regulatory Scrutiny

What makes pharmaceutical meeting venue selection different from other events?

Pharmaceutical companies operate under strict regulations when hosting or sponsoring events that involve HCPs (Healthcare Professionals — doctors, nurses, pharmacists, and other licensed practitioners). These rules exist to prevent industry hospitality from influencing prescribing decisions. In Europe, the EFPIA Code (European Federation of Pharmaceutical Industries and Associations) governs venue selection. In the United States, the Physician Payments Sunshine Act requires disclosure of all transfers of value to HCPs, including hospitality.

The practical impact on venue selection is significant: you cannot book a luxury resort for a medical advisory board. The venue must be "conducive to the scientific programme" and cannot itself be a reason to attend. According to EFPIA's 2024 compliance report, 14% of pharmaceutical meeting compliance violations in Europe involved venue-related issues — predominantly hotels classified as too luxurious or located in tourist destinations without scientific justification.¹

What are the key compliance rules that affect hotel selection?

Three regulatory frameworks shape pharma venue decisions in Europe:

1. EFPIA Code of Practice

The EFPIA Code requires that venues for HCP events are "appropriate and conducive to the main purpose of the event." This means:

• The hotel must be in a location with a legitimate scientific rationale (near a hospital, research centre, or congress venue)
• The venue should not be "renowned for its entertainment facilities" — a code phrase that flags resort-style properties
• Hospitality must not exceed what HCPs would normally pay for themselves
• The meeting must take place in a professional setting with dedicated meeting rooms

2. National pharma codes

Individual countries layer additional rules on top of EFPIA. France's Loi Bertrand requires prior authorisation for HCP events. Germany's FSA Code specifies per-diem hospitality caps. The UK's ABPI Code prohibits venues where "the choice of venue could be seen as an inducement."

3. US Sunshine Act (for global meetings)

If US-licensed HCPs attend your European meeting, all transfers of value (including meals, accommodation, and travel) must be reported to CMS (Centers for Medicare and Medicaid Services). This applies even when the meeting is held outside the US. The Open Payments database publishes these figures publicly, creating reputational risk if hospitality appears excessive.

How do you evaluate whether a hotel is "compliant" for a pharma meeting?

There is no official approved-venue list. Compliance is assessed against principles, not a checklist. However, experienced pharma meeting planners use these evaluation criteria:

• Star rating — 3-star to 4-star business hotels are generally safe. 5-star properties require strong justification (e.g., it is the only hotel near the congress venue with sufficient meeting space)
• Location rationale — city-centre or airport-adjacent hotels near medical institutions are defensible. Beach resorts, ski resorts, and golf resorts are difficult to justify unless the meeting is an established annual congress at that location
• Hotel branding — even within a 4-star category, a hotel marketed as a "spa and wellness retreat" carries more compliance risk than a "business and conference hotel" with the same star rating
• Recreational facilities emphasis — a hotel that happens to have a pool is fine. A hotel whose primary marketing features golf, spa packages, or beach clubs is problematic
• Season and pricing — booking a hotel in a tourist destination during peak season at peak rates is harder to defend than the same hotel in the off-season at business rates

GBTA's 2025 pharma travel survey found that 62% of pharma companies now require venue pre-approval from their compliance department before an RFP is issued, up from 41% in 2020.²

What should a pharma meeting RFP include for compliance purposes?

Your RFP (Request for Proposal) for a pharma meeting needs to capture information that a standard corporate RFP would not. Include these requirements:

• Itemised billing — request that the hotel provides separate line items for accommodation, F&B (Food and Beverage), meeting rooms, AV, and any other charges. Bundled pricing makes Sunshine Act reporting impossible
• Per-person cost breakdown — compliance teams need per-HCP costs. Ask hotels to quote on a per-person basis, not just a total group rate
• Room category specification — specify standard rooms only (no suites, no upgrades). If the hotel automatically upgrades VIPs, flag this as a compliance issue
• Meal cost caps — state your company's per-person meal budget cap (typically EUR 60-100 for dinner, EUR 30-50 for lunch in Western Europe) and ask hotels to design menus within these limits
• No entertainment or leisure inclusions — explicitly state that spa credits, golf packages, entertainment, and leisure activities must not be included in the proposal
• Meeting-room-to-bedroom ratio — ensure the hotel has dedicated, professional meeting space. A pharma meeting in a hotel restaurant closed for the morning looks unprofessional and raises questions

What types of pharma meetings have the strictest venue requirements?

The level of compliance scrutiny varies by meeting type. From most restrictive to least:

• Advisory boards — 8-20 HCPs providing expert input. Highest scrutiny. Must be at a business hotel near the company's offices or a medical centre. No destination travel
• Investigator meetings — for clinical trial site staff. Professional setting, usually near the sponsor's research facility or a centralised hub airport city
• Product launches / symposia — typically co-located with a medical congress. The congress venue or its official hotel list provides automatic justification
• Medical education events — CME (Continuing Medical Education) accredited events have the most flexibility because the educational content itself justifies the gathering
• Internal training — meetings for the company's own medical science liaisons or sales teams (no external HCPs). Normal corporate venue rules apply, though many companies still enforce pharma-grade standards

Cvent data shows that pharma meetings account for 11% of all European group hotel RFPs but generate 18% of hotel revenue due to their typically higher service requirements and willingness to commit to contracted minimums.³

How should you document venue selection for compliance audits?

Pharmaceutical companies are audited regularly — both internally and by industry bodies like the PMCPA (UK) or AFSSAPS (France). Your venue selection documentation should include:

• Venue selection rationale — a written statement explaining why this hotel was chosen (proximity to medical facility, best meeting-space-to-cost ratio, established congress hotel)
• Comparison evidence — at least 3 proposals from different hotels showing you selected based on merit, not personal preference. An RFP tool like Easy RFP generates this comparison automatically
• Cost benchmarking — evidence that the per-person cost falls within your company's hospitality caps and is in line with market rates for the destination
• Compliance pre-approval — the sign-off from your medical affairs or compliance team confirming the venue is appropriate
• Final invoice with itemised costs — matched against the original proposal for accuracy

Maintaining this documentation is not optional. EFPIA member companies face fines of up to EUR 500,000 for systematic venue compliance violations, and individual incidents can result in public naming in industry compliance reports.

What budget benchmarks apply to compliant pharma meetings in Europe?

Pharma meeting budgets are constrained by hospitality caps, but the overall cost per attendee can still be significant due to the professional meeting infrastructure required:

• Advisory board (1 day, no overnight): EUR 150-300 per HCP (meeting room, lunch, coffee breaks)
• Advisory board (1 night): EUR 350-600 per HCP (accommodation, meeting room, dinner, breakfast)
• Investigator meeting (2 nights): EUR 600-1,000 per attendee
• Satellite symposium at congress: EUR 200-500 per attendee (meeting room hire at congress venue plus refreshments)

These figures exclude HCP travel costs, speaker fees, and honoraria, which are tracked separately under transfer-of-value reporting. STR data shows that 4-star business hotel rates in major European pharma hub cities (Basel, Frankfurt, London, Paris) averaged EUR 185 per night in Q1 2026.